Trade Summary

2 days ago, WILSON TROY EDWARD, serving as President and CEO at Kura Oncology, Inc. (KURA), purchased 100,000 shares at $11.12 per share, for a total transaction value of $1,112,000.00. Following this transaction, WILSON TROY EDWARD now holds 379,194 shares of KURA.

This purchase represents a 35.82% increase in WILSON TROY EDWARD's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 17, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 17, 2026 at 4:45 PM ET, meaning the disclosure happened on the same day as the trade.

Kura Oncology, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.